Keros Therapeutics Inc (KROS)
60.35
-2.72
(-4.31%)
USD |
NASDAQ |
Nov 14, 16:00
60.35
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| Regeneron Pharmaceuticals Inc | 86.80% |
| Scholar Rock Holding Corp | -- |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Palatin Technologies Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.60% |
| Return on Assets | -40.96% |
| Return on Invested Capital | -44.60% |
| Profit Margin (Quarterly) | -13.65K% |
| Operating Margin (Quarterly) | -15.12K% |
| Return on Net Operating Assets | -456.8% |